Ivan Berkes

CEO of London Pharma Capital

📍 United Kingdom🔄 Updated October 2026💼 2 investments📅 10 years investing🗓 Last invested Oct 2017
VC🌍 United Kingdom
2
Total investments
0
Early stage
0
Mid stage
0
Late stage
10y
Years active

Portfolio

2 investments · sorted by recency
All investments
Early stage
Mid stage
Late stage
Investor and NED
Oct 2017
For 150 years, Jeyes (now Easy Cleaning Solutions) has led the development of effective and affordable cleaning solutions in the UK. For nearly 50 years we have operated from one of the largest integrated cleaning products factories in Europe, producing our own brands, those of other brand owners and private label, each supported by a significant research & development resource. What really makes ECS unique is that you also get flexible additional services for long term partners. We have an open book development approach in formulation and design packaging to match specific customer needs. We are a privately owned business with a long term strategy, able to make long term decisions with significant capital available to fund investments in plant, people and product.
Investor and Advisory Board Member
Mar 2016
Improve customer satisfaction, increase product innovation, generate new revenue streams, and make significant operational savings. All with the only proven end-to-end, AI-powered operating system for energy utilities. Now expanded to support water, and telco.
Experience · 9 entries
All (9)
Investments (2)
Founder (3)
2026
Founder
Jan 2026
QREAN is a health-tech startup dedicated to modernizing how medicinal information is delivered, accessed, and experienced. Our mission is to enable the gradual removal of traditional Patient Information Leaflets (PILs) from medicinal packaging and replace them with a fully digital, compliant, content-rich, and user-centric solution: the Unified Medication Interface (UMI). UMI is an electronic interface designed to deliver verified, up-to-date medicinal information directly to mobile phones and digital devices. It improves accessibility for patients while supporting pharmacists and healthcare professionals with reliable, current content. We officially unveiled and promoted our solution at Pharmapack 2026 in Paris, engaging with pharmaceutical manufacturers, regulators, and technology partners who share our vision for a smarter and more sustainable future for medicines. By shifting from paper to digital, QREAN enables: • Enhanced user experience through interactive, multilingual, and accessible content beyond traditional ePI • Support for adherence management • Improved safety and regulatory compliance through real-time updates and version control • Environmental benefits through reduced paper waste and packaging materials • Lower production and logistics costs via simplified packaging and faster update cycles • The ability to detect and manage counterfeiting risks at the point of care and across the supply chain Our broader aim is to promote better ways of bringing medicines to consumers in a digital-first world—without compromising safety, regulation, or trust. Japan has already demonstrated that this transition is achievable. Between 2019 and 2024, regulatory reform and industry collaboration enabled the large-scale adoption of electronic medicinal information systems. With the right commitment from regulators, industry, and stakeholders, Europe could reach a similar level of maturity by 2028–2029. We believe this change is not only possible—it is necessary.
2019
Managing Director
Feb 2019
PXG Pharma is one of Europe’s leading manufacturers of premium private label healthcare products and licensed medicines. Imprint: https://www.pxgpharma.com/en/imprint
2017
Investor and NED
Oct 2017
For 150 years, Jeyes (now Easy Cleaning Solutions) has led the development of effective and affordable cleaning solutions in the UK. For nearly 50 years we have operated from one of the largest integrated cleaning products factories in Europe, producing our own brands, those of other brand owners and private label, each supported by a significant research & development resource. What really makes ECS unique is that you also get flexible additional services for long term partners. We have an open book development approach in formulation and design packaging to match specific customer needs. We are a privately owned business with a long term strategy, able to make long term decisions with significant capital available to fund investments in plant, people and product.
2016
Investor and Advisory Board Member
Mar 2016
Improve customer satisfaction, increase product innovation, generate new revenue streams, and make significant operational savings. All with the only proven end-to-end, AI-powered operating system for energy utilities. Now expanded to support water, and telco.
2015
CEO
Dec 2015
Welcome to London Pharma Capital. We are a new kind of pharmaceuticals business which places superior, aspirational healthcare products within customers reach. The company is dedicated to building bespoke partnerships with pharmacies and healthcare retailers to create market leading, private label products. Our team of world-class experts develop and manufacture premium, private-label product ranges in the pharmaceutical and healthcare sector. We have also devised an innovative model for working with pharmacies and retailers that ensures we share the benefits equitably so as to build long-term, sustainable partnerships. Private label is a huge contributor to the profitability of market leading pharmacy chains such as Boots, Walgreens and Dr Max. We have proven the model at scale, creating a significant amount of value for all parties. We are now bringing this capability to new markets by opening up our team to new potential partners. Our product proposition is focused on premium healthcare products that deliver an aspirational experience to customers. The positioning is ‘premium products at better value’ through attractive, high-finish packaging and superior product performance vs. branded alternatives. The company was founded in 2015 by Ivan Berkes, Jonathan Farrington and Simon Dorris. Please contact us directly to find out more.
Show all 9 entries ↓